EGFR and non-small cell lung carcinoma: In the current study, as shown in Figure 8, we show that a combination of apigenin + gefitinib in EGFR-mutated, TKI-resistant NSCLC will induce metabolic stress and energetic disturbance in H1975 cells, which lead to apoptotic cell death.